Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Simple Search

Search Type: Criteria:

You could also try: resembling (46)

Welcome to the general intensive care unit (GICU) - patient information

Description: A guide to the general intensive care unit (GICU) for relatives and friends.
Url: /Media/UHS-website-2019/Patientinformation/Visitinghospital/Welcome-to-the-general-intensive-care-unit-GICU-2254-PIL.pdf

Risk-reducing bilateral salpingo-oophorectomy - patient information

Description: This booklet explains what a risk-reducing bilateral salpingo-oophorectomy is and what the operation involves to help you decide whether
Url: /Media/UHS-website-2019/Patientinformation/Genetics/Risk-reducing-bilateral-salpingo-oophorectomy-1434-PIL.pdf

WHP Funding Call EOI_01.03.24

Description: Funding Call – Round 1 - PILOT Expression of Interest About Wessex Health Partners: 1. Wessex Health Partners (WHP) is the region’
Url: /Media/Southampton-Clinical-Research/Downloads/WHP-Funding-Call-EOI-01.03.24.docx

Fetal anaemia - patient information leaflet

Description: Fetal anaemia occurs during pregnancy, when the levels of red blood cells in an unborn baby's blood are lower than normal
Url: /Media/UHS-website-2019/Patientinformation/Pregnancyandbirth/Fetal-anaemia-3282-PIL.pdf

AmB - Brexucel - Cyclophosphamide (500) - Fludarabine (30)

Description: Chemotherapy Protocol CHIMERIC ANTIGEN RECEPTOR T-CELL (CAR-T) THERAPY Mantle Cell lymphoma (MCL) AmB – BREXUCEL – CYCLOPHOSPHAMIDE (500) – FLUDARABINE (30) Ambulatory
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/AmB-Brexucel-Cyclophosphamide-500-Fludarabine-30-Ver-1.pdf

Tisacel-Cytarabine (500)-Etoposide (150)

Description: Chemotherapy Protocol CHIMERIC ANTIGEN RECEPTOR T-CELL (CAR-T) THERAPY ALL – TISACEL – CYTARABINE (500) – ETOPOSIDE (150) Regimen This regimen will only
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/ALL/Tisacel-Cytarabine-500-Etoposide-150.pdf

Finance and Performance Reports 2023-24 Month 6 September 2023

Description: Report to the Trust Board of Directors Title: Agenda item: Sponsor: Author: Date: Purpose Finance Report 2023-24 Month 6 12
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Trust-governance-and-corporate-docs/2023-Trust-documents/Finance-and-Performance-Reports-2023-24-Month-6-September-2023.pdf

Making your advance care plan (BMT and cellular therapy) - patient information

Description: This booklet is about how to make an advance care plan. An advance care plan is a record of your thoughts
Url: /Media/UHS-website-2019/Patientinformation/Cancercare/Making-your-advance-care-plan-BMT-and-cellular-therapy-3623-PIL.pdf

UHS Patient safety incident response plan

Description: Patient safety incident response plan Effective date: 2nd October 2023 Estimated refresh date:2nd October 2024 with informal review after the
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Plans-and-strategies/UHS-Patient-safety-incident-response-plan.pdf

Tisacel - Cyclophosphamide (500) - Fludarabine (30)

Description: Chemotherapy Protocol CHIMERIC ANTIGEN RECEPTOR T-CELL (CAR-T) THERAPY ALL – TISACEL– CYCLOPHOSPHAMIDE (500) – FLUDARABINE (30) Regimen This regimen will only
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/ALL/Tisacel-Cyclophosphamide-500-Fludarabine-30-Ver1.pdf

641 to 650 of 761

Previous … 63 64 65 66 67 … Next